Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration

Key Points

• The aim is to evaluate the effectiveness of desmopressin in preventing bleeding after non-focal renal biopsy.
• Administered desmopressin (DDAVP) before the renal biopsy procedure.
• Monitored patients for clinically significant bleeding post-biopsy.
• Desmopressin administration significantly decreased the occurrence of hemorrhagic complications.
• Supports the use of desmopressin as a prophylactic measure in renal biopsy.